A nurse is caring for a 45-year-old male client with acquired immunodeficiency syndrome (AIDS) who has a CD4+ T cell count of 180 cells/mm³. The client reports feeling fatigued and has developed white patches in the mouth. Vital signs are: temperature 100.2°F (37.9°C), blood pressure 110/70 mmHg, heart rate 88 bpm, respirations 20/min. Which nursing intervention should be the highest priority to ensure client safety?

With a CD4+ T cell count of 180 cells/mm³, this client has severe immunocompromise and is at extremely high risk for opportunistic infections. The white patches in the mouth likely indicate oral candidiasis (thrush), and the low-grade fever suggests possible infection. Implementing strict infection control precautions and protective isolation is the highest priority to prevent exposure to additional pathogens that could be life-threatening.

This question assesses critical thinking in determining the priority of nursing interventions for a severely immunocompromised patient. A CD4+ T cell count of 180 cells/mm³ indicates severe immunodeficiency; the normal range is 500–1200 cells/mm³. At this level, the risk of life-threatening opportunistic infections is extremely high.

The clinical presentation suggests an active infection, with oral candidiasis (thrush) appearing as white patches in the mouth and a low-grade fever indicating possible systemic involvement. The patient's immune system is so severely compromised that it cannot effectively fight off even normally harmless microorganisms.

Strict infection control precautions and protective isolation are the top priority because they directly address the most immediate threat to the patient's life: exposure to additional pathogens. This includes using standard precautions, restricting visitors, ensuring proper hand hygiene by all healthcare staff, and creating a protective environment.

Antiretroviral medications are important for long-term management, but immediate protection from infection takes precedence. Hydration and emotional support are helpful but do not address the critical safety issue of preventing life-threatening infections in a severely immunocompromised patient.